Annual Quaterly

Annual

Quaterly

Operating Results Financial condition Cash Flows Per share data Major Indicators Segments Data Drug Fostering Program formulations "Growing"formulations Other

Operating Results Financial condition Cash Flows Segments Data Drug Fostering Program formulations "Growing"formulations Other

Other

*Japanese GAAP

(Unit：millions of yen)

	2022/4Q	2023/1Q	2023/2Q	2023/3Q	2023/4Q	2024/1Q	2024/2Q	2024/3Q	2024/4Q	2025/1Q	2025/2Q	2025/3Q
Investments	14,679	3,889	7,649	12,494	21,908	2,310	8,181	21,392	31,077	4,088	18,182	28,866
Capital investments	11,172	2,660	5,903	10,128	18,352	2,240	7,456	19,904	28,650	3,499	17,286	27,799
R&D expenses	7,594	2,218	4,215	6,132	8,288	2,269	4,237	6,200	8,355	2,212	3,988	6,225
Depreciation	10,101	2,454	4,928	7,583	10,235	2,671	5,329	7,931	10,620	2,827	5,663	8,715

1.Financial year ends on the 31st March
2.The numerical value serves as the total
3.From year ending 31 March 2023, the "acquisition of property, plant and equipment" has been changed to "investment amount of property, plant and equipment and software, etc."

provided by StockWeather.com,Inc.